Federal lawmakers are still considering drug price controls through a Senate budget reconciliation bill.

However, current proposals including Medicare negotiation will devastate Virginia’s innovation economy, resulting in less research and development (R&D) leading to groundbreaking treatments for Virginians living with critical conditions.

Current drug pricing proposals threaten the very innovation that so many patients here in Virginia rely on. But you have an opportunity to raise your voice and tell your lawmakers that this proposal will harm Virginia patients, jobs, and our innovation economy. Take action today.